Table 7 Treatment emergent adverse events reported after second dose
Second Dose → | Placebo | Lasmiditan 50 mg | Lasmiditan 100 mg | Lasmiditan 200 mg | |||
|---|---|---|---|---|---|---|---|
Placebo | Placebo | Lasmiditan 50 mg | Placebo | Lasmiditan 100 mg | Placebo | Lasmiditan 200 mg | |
Rescue populationa | 60/669 (9.0) | 12/79 (15.2) | 31/166 (18.7) | 25/142 (17.6) | 55/299 (18.4) | 27/119 (22.7) | 45/235 (19.1) |
Recurrence populationa | 2/29 (6.9) | 0/4 | 2/9 (22.2) | 1/10 (10.0) | 3/36 (8.3) | 3/16 (18.8) | 3/27 (11.1) |